Fig. 1From: Prognostic significance of the pre-chemotherapy lymphocyte-to-monocyte ratio in patients with previously untreated metastatic colorectal cancer receiving FOLFOX chemotherapyKaplan–Meier estimates of progression-free and overall survival of patients with newly diagnosed metastatic colorectal cancer stratified by pre-treatment ALC (a, b), AMC (c, d), and LMR (e, f). ALC absolute lymphocyte count, AMC absolute monocyte count, LMR lymphocyte-to-monocyte ratioBack to article page